Dr. med. Rafaela Kramer

Department of Dermatology

Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors (2024) Ruf T, Kramer R, Forschner A, Leiter U, Meier F, Reinhardt L, Dücker P, et al. Journal article Standardized Computer-Assisted Analysis of PRAME Immunoreactivity in Dysplastic Nevi and Superficial Spreading Melanomas (2023) Koch E, Erdmann M, Berking C, Kiesewetter F, Kramer R, Schliep S, Heppt M Journal article Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors (2023) Nuñez NG, Berner F, Friebel E, Unger S, Wyss N, Gomez JM, Purde MT, et al. Journal article Conventional and three-dimensional photography as a tool to map distribution patterns of in-transit melanoma metastases on the lower extremity (2023) Müller K, Berking C, Voskens C, Heppt M, Heinzerling L, Koch E, Kramer R, et al. Journal article Characterization of the impact of immune checkpoint inhibitors on platelet activation and aggregation (2023) Schlüter J, Cunningham S, Zimmermann R, Achenbach S, Kramer R, Erdmann M, Beckmann M, et al. Journal article In vitro assessment of checkpoint-induced cytokine levels as new tool in the therapeutic decision-making process after checkpoint-induced cytokine release syndrome in metastatic melanoma (2022) Kramer R, Bender-Säbelkampf S, Berking C, Heppt M, Erdmann M, Bosch-Voskens C Conference contribution Checkpoint-inhibitor induced Polyserositis with Edema (2022) Zierold S, Akcetin LS, Gresser E, Maier AM, Koenig A, Kramer R, Theurich S, et al. Journal article Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition — A Descriptive Observational Retrospective Multicenter Analysis (2021) Zaremba A, Kramer R, De Temple V, Bertram S, Salzmann M, Gesierich A, Reinhardt L, et al. Journal article Response to letter entitled: ‘Re: Hematological immune related adverse events after treatment with immune checkpoint inhibitors’ (2021) Heinzerling L, La Rosée P, Gutzmer R, Kramer R, Keller-Stanislawski B, Zierold S, Mentzer D Journal article Hematological immune related adverse events after treatment with immune checkpoint inhibitors (2021) Kramer R, Zaremba A, Moreira A, Ugurel S, Johnson DB, Hassel JC, Salzmann M, et al. Journal article